17-40289482-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001254.4(CDC6):c.62G>A(p.Arg21Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,613,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001254.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDC6 | NM_001254.4 | c.62G>A | p.Arg21Gln | missense_variant | 2/12 | ENST00000209728.9 | NP_001245.1 | |
CDC6 | XM_011525541.3 | c.62G>A | p.Arg21Gln | missense_variant | 2/13 | XP_011523843.1 | ||
CDC6 | XM_011525542.2 | c.62G>A | p.Arg21Gln | missense_variant | 2/13 | XP_011523844.1 | ||
CDC6 | XM_047437207.1 | c.62G>A | p.Arg21Gln | missense_variant | 2/12 | XP_047293163.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDC6 | ENST00000209728.9 | c.62G>A | p.Arg21Gln | missense_variant | 2/12 | 1 | NM_001254.4 | ENSP00000209728 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151856Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251480Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135914
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461818Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727214
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151974Hom.: 0 Cov.: 31 AF XY: 0.0000808 AC XY: 6AN XY: 74254
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.62G>A (p.R21Q) alteration is located in exon 2 (coding exon 1) of the CDC6 gene. This alteration results from a G to A substitution at nucleotide position 62, causing the arginine (R) at amino acid position 21 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 08, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with CDC6-related conditions. This variant is present in population databases (rs193089010, gnomAD 0.02%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 21 of the CDC6 protein (p.Arg21Gln). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at